3rd AMERICA DRUG SAFETY & AI 2025

World’s greatest minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology united under the Why Summits Future of Pharmacovigilance World Tour

key information

What to expect

 AI is already used in pharmacovigilance, but discussions often remain surface-level. As validated tools emerge, the focus shifts from if to how – gaining competitive advantage, ensuring transparency, and extracting value from new technologies. Regulators like EMA and FDA offer guidance, yet challenges persist around validating learning systems, justifying AI-driven signals, and shaping regulations.

AI is also changing PV roles, requiring new skills and workforce retraining. Ethical concerns like bias and underrepresentation must be addressed. We invite you to explore these critical issues at the 3rd AMERICA DRUG SAFETY & AI 2025.

Main takeaways

BENEFITS OF ATTENDING

  • Forward-Looking Insights: Discover the latest trends, challenges, and advancements in pharmacovigilance from world-renowned industry leaders. Prepare for the future of drug safety with actionable strategies.
  • Unparalleled Networking: Build connections with senior executives, regulatory specialists, and industry pioneers. Expand your professional network and collaborate with like-minded experts to drive innovation.
  • Comprehensive Engagement: Participate in interactive discussions and hands-on sessions tackling key issues like emerging technologies, regulatory changes, and operational excellence, all led by top professionals.
  • Global Expertise: Gain a worldwide perspective on the pharmacovigilance landscape, with insights into international regulations, diverse market environments, and strategies for effective global collaboration.
  • Knowledge Exchange: Share experiences, learn best practices, and explore cutting-edge solutions to enhance your organization’s safety and compliance frameworks.

Target audience breakdown:

Summit Aligned with the 7 I's:

  • Intelligence: Insights from senior stakeholders with expertise in drug safety
  • Ideas: Exploring emerging trends and opportunities
  • Interaction: Benchmarking the best strategies in the industry
  • Inspiration: Discovering new approaches and how to leverage them
  • Innovation: Enhancing the effectiveness of PV organizations
  • Implementation: Turning plans into impactful actions
  • Improvement: Striving for excellence in pharmacovigilance

Elevate Your PV Game:
Mastering the 5 W’s

Who, What, When, Where, and Why are the cornerstones of effective process management and continuous improvement. Asking the right questions leads to meaningful answers—enabling you to set up processes with precision and drive greater effectiveness.

At our summit, dive into HOW to turn these foundational elements into actionable strategies that deliver measurable results. Learn. Innovate. Lead.

Event Speakers

Jean Redmond

Chief Operating Officer

Biologit

Tarak Thakker

Head of Safety Systems - Director Digital PV and Decision Support

BeiGene

Alok Singh

Global AI Product Manager, Analytics & Generating Insights - Product Development Informatics

Roche

Sudhir Shandilya

Director, Digital Delivery & Operations

Sanofi

Monica Jain

Director, R&D Data Science

J&J Innovative Medicine

Shruti Vij

Digital Transformation Lead

Takeda

Slava Akmaev

Chief AI Officer, Interim Chief Operating Officer

BPGBio

Anupam Aich

Domain Lead, Product Definition, Digital Pathology Clinical AI/ML Algorithms SaMD

Roche

Bahareh Kilcoyne

R&D Quality Data Scientist

J&J

Garrett Manasco

Associate Director, Clinical Artificial Intelligence

AbbVie

Event Partners

Industry Pioneers Attending From

Testimonials

Rated 5 out of 5
Participating in the American Drug Safety Summit was a truly rewarding experience. The energy in the room, the depth of conversations, and the shared commitment to transforming pharmacovigilance made it an inspiring and impactful event. I walked away with new perspectives, meaningful connections, and a strong sense of momentum for what’s ahead.
Gigi Atalla​​​​
Vice President, Head of Global Drug Safety & Pharmacovigilance, Genmab
Rated 5 out of 5
I thoroughly enjoyed the interactive and spontaneous discussions on key pharmacovigilance topics, ranging from Gen AI to PV regulatory frameworks. The conference brought together a focused group of PV professionals, providing ample opportunities to connect and network with like-minded individuals. Overall, it was a successful conference and met its objectives.
Karthik Babu
Consumer Healthcare Global PV Operations Head, Sanofi
Rated 5 out of 5
Fabulous meeting today, Lubos. This is a fabulous opportunity for us to shape the future, not just that we can be the conduit to current advances, but we can go beyond that with our military grade solutions.
Robert Huber
Co-Founder and Chief Product Officer, Veridat
Rated 5 out of 5
I thoroughly enjoyed participating in the Why Summits pharmacovigilance conference. The topics were not only timely and relevant but also deeply engaging, sparking meaningful discussions. I especially appreciated the collaborative atmosphere, which created a great opportunity to connect with colleagues across the field and exchange valuable insights.
Mina Ebeid 
Director, Global Drug Safety, Genmab
Rated 5 out of 5
The American Drug Safety Summit 2025 was a great event to learn from industry experts about the evolution of patient safety. It was very interesting to see how AI is being leveraged in data-intensive projects to improve patient outcomes. The introduction to the REMS Industry Consortium was a highlight, and their work is truly inspiring.
Apoorva Anil Joshi
Senior Pharmacovigilance Product Scientist, Genentech
Rated 5 out of 5
This event provided great opportunity to network with Industry peers & thought leaders and explore new ways of working. Especially in the new AI era; “on  how Pharmacovigilence industry is progressing and how we need to adapt to the change”. Insights from presentations and panel discussions are adorable . I left with great ideas and new connections in my network to collaborate with and grow further.
Vasudev Sureddy
Executive Director & COO, ADVITY RESEARCH

Everything you need to know about this event in one spot.

Check out our event overview and agenda and discover this conference.

REGISTRATION

PHARMA & BIOTECH

Ticket | December 9-10, 2025
$ 2349
  • Access to all conference sessions
  • Access to all networking activities during the conference
  • Conference materials
  • Coffee breaks with snacks and refreshments
  • Networking lunch

SOLUTION-PROVIDERS & VENDORS

Ticket | December 9-10, 2025
$ 3049
  • Access to all conference sessions
  • Access to all networking activities during the conference
  • Conference materials
  • Coffee breaks with snacks and refreshments
  • Networking lunch

BECOME A PARTNER

OF this EVENT
  • Present on the Main Stage
  • Hold an exhibit at this event
  • Showcase your Brand in Marketing Material
  • Gain exposure through alternative partnership benefits

Agenda Download

Submission Successful!

Thank you for your interest! The agenda has been sent to your email. Click the button below if you want to open the agenda in a new tab.

Conference
10-Pack for Teams

10 Tickets for your team

One package. Access to any Why Summits’ conferences, with flexible selection via email throughout the year.

$9,990 / €9,990

Please note: This offer is not applicable to solution providers, software vendors, or consulting companies.

Not sure which conferences to choose for your team?

Leave your details and our team will help you plan the best conference mix for 2026.

Submission Successful!

Your information has been received.